Research advances in the application of telbivudine during pregnancy to prevent HBV mother-to-child transmission

Research advances in the application of telbivudine during pregnancy to prevent HBV mother-to-child transmission

Almost 10% of neonates whose mothers have a high HBV DNA load may have HBV infection, even after the preventive treatment with hepatitis B vaccine and immune interruption. In pregnant women with a high HBV DNA load, nucleos(t)ide analogues (lamivudine, telbivudine, and tenofovir) have been used in t...

Full description

Bibliographic Details
Main Authors: WANG Chong, CAO Mengzhuo, WANG Chuan
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2017-04-01
Series:Linchuang Gandanbing Zazhi
Subjects:
hepatitis B virus
disease transmission
vertical
therapy
pregant women
review
Online Access:http://www.lcgdbzz.org/qk_content.asp?id=8145

Internet

http://www.lcgdbzz.org/qk_content.asp?id=8145

Similar Items